Pharmatest offers high quality preclinical efficacy studies in oncology and skeletal diseases. In skeletal diseases our services include “in vitro” bone cell assays and “in vivo” models of osteoporosis, osteoarthritis, and bone safety testing. In oncology our focus is in orthotopic and metastasis models, with special expertise in bone metastases.



Andrew Heiniluoma Business Development Director, Pharmatest USA Phone: 978 340 1028 (USA)
Dr. Jukka Rissanen CEO Phone: +358 50 380 9551 (Finland)
Itäinen Pitkäkatu 4C 20520 Turku Finland